Diligence memo · auto-generated · as of July 2, 2026

Osteon Holdings, Inc.

Osteon Holdings, Inc. has raised $617M over 1 round; too few niche peers to rank its valuation yet.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Osteon Holdings, Inc. operates in Pharma, based in FORT WORTH. Services – Osteon Holdings

Sub-sector tags: healthtech, pharma.

Capital & rounds (filed)filed

Osteon Holdings, Inc. has raised $617M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Growth/Late (a round over $400M).

Largest single filing: $617M on 2018-02-14.

Most recent recorded round closed around 2018-02-14.

Valuation (modeled)modeled

Provath models Osteon Holdings, Inc. at approximately $22.4B (range $4.0B–$40.4B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Too few comparable companies in this niche to rank the valuation fairly yet.

Financing rhythm & timingmixed

Last raise 8.4 yr ago; this sector typically re-raises about every 16 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 100% of Pharma peers (310 compared).

Modeled value ranks above 100% of those peers.

Peoplefiled

13 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.